Brain Stimulation for Cognitive Functioning

Overseen By Michael Thomas, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Colorado State University

Must not be taking: Brain excitability drugs

Disqualifiers: Seizures, Epilepsy, Neurological, Psychiatric, others

Approved in 3 Jurisdictions This treatment is already approved in other countries

Compensation: Varies

Number of Visits: 1

Duration: 1 hour

100 Participants Needed

Trial Summary

What is the purpose of this trial?

The purpose of this study is to determine optimal task design parameters for the measurement of transcranial magnetic stimulation (TMS) effects on cognition.

Eligibility Criteria

This trial is for right-handed, English-speaking individuals without significant medical or neurological issues. It excludes those with a history of severe headaches, syncope, head injuries, psychiatric disorders, substance abuse, hearing/visual impairments affecting cognition, metal implants in the head/neck (except dental), and certain medical devices.

Inclusion Criteria

Right-handed

Fluent in English

Exclusion Criteria

History of implanted neurostimulator

Inadequate sleep in the 48 hours prior to TMS

History of metal in the head or neck (except braces and fillings)

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants complete cognitive tasks while active versus sham TMS is applied to the brain

1 hour

1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

No follow-up

Treatment Details

Interventions

• Transcranial Magnetic Stimulation

Trial Overview The study is testing how Transcranial Magnetic Stimulation (TMS) affects cognitive task performance. Researchers are looking to find the best parameters for using TMS to measure its impact on cognitive functions.

Participant Groups

Group I: Active TMS Experimental Treatment 1 Intervention

Repetitive TMS for the brain

Group II: Sham TMS Placebo Group 1 Intervention

Scalp stimulation that does not affect the brain.

Who Is Running the Clinical Trial?

Colorado State University

Lead Sponsor

Trials

138

Recruited

38,200+